BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 23448440)

  • 1. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.
    Tomé-Carneiro J; Larrosa M; González-Sarrías A; Tomás-Barberán FA; García-Conesa MT; Espín JC
    Curr Pharm Des; 2013; 19(34):6064-93. PubMed ID: 23448440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wine, resveratrol and health: a review.
    Guerrero RF; García-Parrilla MC; Puertas B; Cantos-Villar E
    Nat Prod Commun; 2009 May; 4(5):635-58. PubMed ID: 19445315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy.
    Liu BL; Zhang X; Zhang W; Zhen HN
    Cancer Biol Ther; 2007 Dec; 6(12):1833-6. PubMed ID: 18087218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review).
    Wu JM; Wang ZR; Hsieh TC; Bruder JL; Zou JG; Huang YZ
    Int J Mol Med; 2001 Jul; 8(1):3-17. PubMed ID: 11408943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol and health--a comprehensive review of human clinical trials.
    Smoliga JM; Baur JA; Hausenblas HA
    Mol Nutr Food Res; 2011 Aug; 55(8):1129-41. PubMed ID: 21688389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms.
    Sinha D; Sarkar N; Biswas J; Bishayee A
    Semin Cancer Biol; 2016 Oct; 40-41():209-232. PubMed ID: 26774195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol: a review of preclinical studies for human cancer prevention.
    Athar M; Back JH; Tang X; Kim KH; Kopelovich L; Bickers DR; Kim AL
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):274-83. PubMed ID: 17306316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review).
    Aziz MH; Kumar R; Ahmad N
    Int J Oncol; 2003 Jul; 23(1):17-28. PubMed ID: 12792772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol and cardiovascular system-the unfulfilled hopes.
    Chudzińska M; Rogowicz D; Wołowiec Ł; Banach J; Sielski S; Bujak R; Sinkiewicz A; Grześk G
    Ir J Med Sci; 2021 Aug; 190(3):981-986. PubMed ID: 33219913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol.
    Gusman J; Malonne H; Atassi G
    Carcinogenesis; 2001 Aug; 22(8):1111-7. PubMed ID: 11470738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of resveratrol in diabetes: rationale, strategies and challenges.
    Bagul PK; Banerjee SK
    Curr Mol Med; 2015; 15(4):312-30. PubMed ID: 25941821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases.
    Zordoky BN; Robertson IM; Dyck JR
    Biochim Biophys Acta; 2015 Jun; 1852(6):1155-77. PubMed ID: 25451966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resveratrol in Pharmaceutical Chemistry].
    Orgován G; Noszál B
    Acta Pharm Hung; 2015; 85(4):123-9. PubMed ID: 26964400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol: therapeutic potential for improving cardiometabolic health.
    Pollack RM; Crandall JP
    Am J Hypertens; 2013 Nov; 26(11):1260-8. PubMed ID: 24025725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pharmacological Properties of Red Grape Polyphenol Resveratrol: Clinical Trials and Obstacles in Drug Development.
    Farhan M; Rizvi A
    Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapeutic potential of the chemopreventive phytoalexin resveratrol.
    Pervaiz S
    Drug Resist Updat; 2004 Dec; 7(6):333-44. PubMed ID: 15790544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and bioavailability of trans-resveratrol.
    Wenzel E; Somoza V
    Mol Nutr Food Res; 2005 May; 49(5):472-81. PubMed ID: 15779070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol and derivatives for the treatment of atrial fibrillation.
    Baczkó I; Light PE
    Ann N Y Acad Sci; 2015 Aug; 1348(1):68-74. PubMed ID: 26205342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique properties of polyphenol stilbenes in the brain: more than direct antioxidant actions; gene/protein regulatory activity.
    Doré S
    Neurosignals; 2005; 14(1-2):61-70. PubMed ID: 15956815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.